211 related articles for article (PubMed ID: 1970359)
1. Competitive and noncompetitive N-methyl-D-aspartate antagonists modify hypoxia-induced membrane potential changes and protect rat hippocampal slices from functional failure: a quantitative comparison.
Grigg JJ; Anderson EG
J Pharmacol Exp Ther; 1990 Apr; 253(1):130-5. PubMed ID: 1970359
[TBL] [Abstract][Full Text] [Related]
2. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia.
Goldberg MP; Viseskul V; Choi DW
J Pharmacol Exp Ther; 1988 Jun; 245(3):1081-7. PubMed ID: 2838603
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal.
Raiteri M; Garrone B; Pittaluga A
J Pharmacol Exp Ther; 1992 Jan; 260(1):238-42. PubMed ID: 1370541
[TBL] [Abstract][Full Text] [Related]
4. N-methyl-D-aspartate receptor antagonists are less effective in blocking long-term potentiation at apical than basal dendrites in hippocampal CA1 of awake rats.
Leung LS; Shen B
Hippocampus; 1999; 9(6):617-30. PubMed ID: 10641754
[TBL] [Abstract][Full Text] [Related]
5. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
Carter CJ; Lloyd KG; Zivkovic B; Scatton B
J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
Koek W; Woods JH; Colpaert FC
J Pharmacol Exp Ther; 1990 Jun; 253(3):1017-25. PubMed ID: 2193142
[TBL] [Abstract][Full Text] [Related]
7. Noncompetitive N-methyl-D-aspartate antagonists affect multiple ionic currents.
Rothman S
J Pharmacol Exp Ther; 1988 Jul; 246(1):137-42. PubMed ID: 2455788
[TBL] [Abstract][Full Text] [Related]
8. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
Koek W; Woods JH; Winger GD
J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
[TBL] [Abstract][Full Text] [Related]
9. Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.
Jones SM; Snell LD; Johnson KM
J Pharmacol Exp Ther; 1987 Feb; 240(2):492-7. PubMed ID: 2879908
[TBL] [Abstract][Full Text] [Related]
10. Modulation of ethanol state-dependent learning by dorsal hippocampal NMDA receptors in mice.
Rezayof A; Sharifi K; Zarrindast MR; Rassouli Y
Alcohol; 2008 Dec; 42(8):667-74. PubMed ID: 18774674
[TBL] [Abstract][Full Text] [Related]
11. A phencyclidine recognition site is associated with N-methyl-D-aspartate inhibition of carbachol-stimulated phosphoinositide hydrolysis in rat cortical slices.
Gonzales RA; Moerschbaecher JM
Mol Pharmacol; 1989 Jun; 35(6):787-94. PubMed ID: 2543912
[TBL] [Abstract][Full Text] [Related]
12. NMDA receptor blockers prevents the facilitatory effects of post-training intra-dorsal hippocampal NMDA and physostigmine on memory retention of passive avoidance learning in rats.
Jafari-Sabet M
Behav Brain Res; 2006 Apr; 169(1):120-7. PubMed ID: 16443290
[TBL] [Abstract][Full Text] [Related]
13. The N-methyl-D-aspartate antagonists aminophosphonovaleric acid and MK-801 reduce anoxic damage to dentate granule and CA1 pyramidal cells in the rat hippocampal slice.
Kass IS; Chambers G; Cottrell JE
Exp Neurol; 1989 Feb; 103(2):116-22. PubMed ID: 2563246
[TBL] [Abstract][Full Text] [Related]
14. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
[TBL] [Abstract][Full Text] [Related]
15. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
[TBL] [Abstract][Full Text] [Related]
16. Tiletamine is a potent inhibitor of N-methyl-aspartate-induced depolarizations in rat hippocampus and striatum.
ffRench-Mullen JM; Lehmann J; Bohacek R; Fisher RS
J Pharmacol Exp Ther; 1987 Dec; 243(3):915-20. PubMed ID: 3320347
[TBL] [Abstract][Full Text] [Related]
17. Pregnenolone sulfate enhances long-term potentiation in CA1 in rat hippocampus slices through the modulation of N-methyl-D-aspartate receptors.
Sliwinski A; Monnet FP; Schumacher M; Morin-Surun MP
J Neurosci Res; 2004 Dec; 78(5):691-701. PubMed ID: 15505794
[TBL] [Abstract][Full Text] [Related]
18. Pyrazole, an alcohol dehydrogenase inhibitor, has dual effects on N-methyl-D-aspartate receptors of hippocampal pyramidal cells: agonist and noncompetitive antagonist.
Pereira EF; Aracava Y; Aronstam RS; Barreiro EJ; Albuquerque EX
J Pharmacol Exp Ther; 1992 Apr; 261(1):331-40. PubMed ID: 1313873
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of N-methyl-D-aspartate evoked sodium flux by MK-801.
Ransom RW; Stec NL
Brain Res; 1988 Mar; 444(1):25-32. PubMed ID: 3282615
[TBL] [Abstract][Full Text] [Related]
20. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
